This same research team published a population-based study in The Lancet Psychiatry in 2021 showing an increase in depressive symptoms and decrease in mental well-being among 13–18-year-old adolescents within one year of the global spread of the COVID-19 pandemic. A decline in substance use, in particular cigarette smoking, e-cigarette use and alcohol intoxication, was also observed. Expanding on these findings, this new study shows that the negative effect on adolescent mental health has been persisted up to two years into the pandemic.
“It is worrisome that we still see an increase in mental health problems among adolescents two years into the pandemic. And this is occurring despite social restrictions having been eased in Iceland,” said Thorhildur Halldorsdottir, assistant professor of psychology at Reykjavik University and senior author of the study.
The initial decrease in cigarette smoking and e-cigarette use observed shortly after the arrival of the pandemic was also maintained up to two years into the pandemic. The frequency of adolescent alcohol intoxication, however, appeared to be returning to pre-pandemic levels. “It is of course positive to see that the reduction in cigarette smoking and vaping has been maintained,” said Dr. Ingibjorg Eva Thorisdottir, chief data analyst at Planet Youth and lead author of the study. She continued: “We will need to monitor alcohol intoxication among adolescents in years to come, especially given the increase in mental health problems.”
The association of immigration status, residency, parental social support and nightly sleep duration with adolescent mental health and substance use was also examined in this study. Parental social support and an average of 8 hours or more of sleep per night was associated with better mental health and less substance use among adolescents. The relationship between immigration status and residency with adolescent mental health was less clear. These findings suggest that stress exposure, like the COVID-19 pandemic, affects all adolescents to some extent rather than only vulnerable subgroups.
As such, policy makers should consider implementing large-scale evidence-based prevention efforts focusing on depressive symptoms to mitigate the negative effect of the pandemic,” said John Allegrante, the Charles Irwin Lambert Professor of Health Behavior and Education at Teachers College and professor of sociomedical sciences at Columbia Mailman School of Public Health, and a senior collaborating investigator on the study.
The research was supported by the Icelandic Research Fund.
Columbia University Mailman School of Public Health
Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the fourth largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master’s and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu.